journal article·2023-09Open access

Synthesis of multifunctional superparamagnetic mesoporous ZnMnFe2O4@Fe–CaSiO3 core-shell for medical applications

Aqeel Al-Hamaidah, Mahmood Rezaee Roknabadi, Malek Bagheri Harouni, Bizhan Malaekeh-Nikouei, Asma Mahmoudi, Reza Ghanbari, Alireza Charmforoushan

Abstract

Herein, we report the synthesis of a mesoporous calcium silicate superparamagnetic nanoparticle as ZnMnFe 2 O 4 @Fe–CaSiO 3 core-shell. This core-shell nanocomposite reveals excellent properties such as mesoporous nanocomposite, superparamagnetic at room temperature , low toxicity, large surface area , tunable pore size, and easy surface manipulation. The core nanocomposite (ZnMnFe 2 O 4 ) is synthesized by the hydrothermal method , which shows a superparamagnetic behavior with an excellent saturation magnetization of 52.09 emu/g. The core-shell structure is prepared by a micellar-assisted sol-gel method, which uses a copolymer to create pores in the structure of CaSiO 3 . To improve the magnetic properties of the core-shell structure, different percent of Fe ions (0%, 5%, and 10%) are doped onto the calcium silicate structure; as for 10% Fe, i.e., ZnMnFe 2 O 4 @Fe10–CaSiO 3 , saturation magnetization and coercive magnetic field are 34.543 emu/g and 1Oe, respectively. In this configuration of nanocomposite, the pore volume and superparamagnetic property increase simultaneously. In addition, the core-shell mesoporous ZnMnFe 2 O 4 @Fe–CaSiO 3 nanocomposite reveals comparable mesoporous channels (3.4–6 nm), while the amorphous structure of CaSiO 3 has not been changed. These core-shell mesoporous superparamagnetic nanocomposites are evaluated in terms of drug loading and release using epirubicin (EPI) as a model drug. It is found that the increase of iron ions improves the capacity to stabilize the pH environment. Additionally, the mesoporous Fe–CaSiO 3 nanostructures demonstrate a sustained drug release property that could be used in local drug delivery therapy. Therefore, these mesoporous superparamagnetic nanostructures would be a promising multifunctional platform for local drug delivery, magnetic resonance imaging, magnetic hyperthermia, and bone tissue regeneration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Mesoporous Materials and Catalysis · Layered Double Hydroxides Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Nanocarriers for cancer-targeted drug delivery10.3109/1061186X.2015.1051049 ↗
2. Biodegradable inorganic nanostructured biomaterials for drug delivery
3. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma10.1021/acsnano.9b00661 ↗
4. The effect of different concentrations of calcium silicate-maghemite coating towards magnetic behavior and bioactivity10.17576/jsm-2020-4903-20 ↗
5. Management of common adverse effects of antipsychotic medications10.1002/wps.20567 ↗
6. FGFR a promising druggable target in cancer: molecular biology and new drugs10.1016/j.critrevonc.2017.02.018 ↗
7. Magnetic nanochain-based smart drug delivery system with remote tunable drug release by a magnetic field10.1007/s13206-022-00072-1 ↗
8. Thermo-responsive copolymer coated MnFe2O4 magnetic nanoparticles for hyperthermia therapy and controlled drug delivery10.1016/j.matchemphys.2012.09.035 ↗
9. Liquid–liquid extraction of biomolecules: an overview and update of the main techniques10.1002/jctb.1794 ↗
10. Mabrouk · 2020 · 83
11. Fluorinated contrast agents for magnetic resonance imaging; a review of recent developments10.1039/c1ra00627d ↗
12. Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content10.3109/02656736.2014.913321 ↗
13. Insights on magnetic spinel ferrites for targeted drug delivery and hyperthermia applications10.1515/ntrev-2022-0027 ↗
14. Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications10.1186/s12951-018-0405-7 ↗
15. Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics10.1364/BOE.3.002500 ↗
16. Synthesis and characterization of magnetic iron oxide/calcium silicate mesoporous nanocomposites as a promising vehicle for drug delivery10.1021/am3021284 ↗
17. Role of mesoporous wollastonite (calcium silicate) in mesenchymal stem cell proliferation and osteoblast differentiation: a cellular and molecular study10.1166/jbn.2015.2057 ↗
18. Effect of calcium silicate nanoparticle on surface feature of calcium phosphates hybrid bio-nanocomposite using for bone substitute application10.1016/j.powtec.2019.10.111 ↗
19. Drug–nanocarrier interaction—tracking the local structure of calcium silicate upon ibuprofen loading with X-ray absorption near edge structure (XANES)10.1039/c3cp50699a ↗
20. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores10.1126/science.279.5350.548 ↗
21. Anti-tumor efficacy of c (RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin10.1016/j.biomaterials.2013.12.018 ↗
22. Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs10.1080/17425247.2020.1813713 ↗
23. Synthesis and controlled drug release behavior of micro-mesoporous wollastonite nanoparticles. Effect of calcination temperature on the structural and biodegradability properties10.1016/j.matchemphys.2022.125825 ↗
24. Direct surface functionalization of cellulose nanocrystals with hyperbranched polymers through the anionic polymerization for ph-responsive intracellular drug delivery10.1021/acssuschemeng.9b05231 ↗
25. Hydroxyapatite particles from simulated body fluids with different pH and their effects on mesenchymal stem cells
26. Jiang · 2011 · 2055
27. An easily prepared ferrofluid with high power absorption density and low cytotoxicity for biomedical applications10.1016/j.matchemphys.2020.122752 ↗
28. Excess iron inhibits osteoblast metabolism10.1016/j.toxlet.2009.08.023 ↗
29. Zhang · 2013
30. Regulation of osteoblast differentiation and iron content in MC3T3-E1 cells by static magnetic field with different intensities10.1007/s12011-017-1161-5 ↗
31. Synthesis of SiO2-coated ZnMnFe2O4 nanospheres with improved magnetic properties10.1166/jnn.2005.093 ↗
32. Low temperature facile synthesis of pseudowollastonite nanoparticles by the surfactant-assisted sol-gel method10.1016/j.matchemphys.2020.122629 ↗
33. Synthesis and characterization of magnetic Fe3O4@ CaSiO3 composites and evaluation of their adsorption characteristics for heavy metal ions10.1007/s11356-019-04352-6 ↗
34. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984)10.1351/pac198557040603 ↗
35. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery10.1007/s40199-020-00328-x ↗
36. Preparation and the phase transformation behavior of amorphous mesoporous calcium silicate10.1016/j.micromeso.2007.04.013 ↗
37. Surface area, pore size distribution and microstructure of vacuum getter10.1016/j.vacuum.2010.11.012 ↗
38. Synthesis and application of amine functionalized silica mesoporous magnetite nanoparticles for removal of chromium (VI) from aqueous solutions10.1007/s10934-016-0245-5 ↗
39. Lowell · 2006
40. Ernawati · 2021
41. Glasses with medical applications10.1002/ejic.200390134 ↗
42. Catalytic performance of vanadium incorporated MCM-41 catalysts for the partial oxidation of methane to formaldehyde10.1016/j.apcata.2005.12.013 ↗
43. Sequential desilication–isomorphous substitution route to prepare mesostructured silica nanoparticles loaded with ZnO and their photocatalytic activity10.1016/j.apcata.2013.09.005 ↗
44. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies, Artificial Cells
45. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells10.1080/03639045.2017.1371734 ↗
46. Smart tumor microenvironment‐responsive Nanotheranostic agent for effective cancer therapy10.1002/adfm.202000486 ↗
47. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies, Artificial Cells
48. Substitutions of strontium in mesoporous calcium silicate and their physicochemical and biological properties10.1016/j.actbio.2013.01.021 ↗
49. Bioactive SrO–SiO2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties10.1016/j.actbio.2010.12.018 ↗